{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:12:54Z","timestamp":1793643174879,"version":"4.5.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2017T016"],"award-info":[{"award-number":["2017T016"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201806850094"],"award-info":[{"award-number":["201806850094"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ebiom.2023.104684","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T16:20:19Z","timestamp":1687796419000},"page":"104684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE\u22173-Leiden.CETP mice"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3540-7877","authenticated-orcid":false,"given":"Zhixiong","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2637-3801","authenticated-orcid":false,"given":"Robin","family":"van Eenige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0815-1076","authenticated-orcid":false,"given":"Xiaoke","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"van Marwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost M.","family":"Lambooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8856-5799","authenticated-orcid":false,"given":"Bruno","family":"Guigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Giera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Freark","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebtte R.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-4988","authenticated-orcid":false,"given":"Patrick C.N.","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0014-5571","authenticated-orcid":false,"given":"Sander","family":"Kooijman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ebiom.2023.104684_bib1","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.3748\/wjg.v22.i13.3663","article-title":"Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: an 8-year follow-up study","volume":"22","author":"Lu","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104684_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13235","article-title":"Prevalence and risk factors of fatty liver in Portuguese adults","volume":"50","author":"Leit\u00e3o","year":"2020","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104684_bib3","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 global NAFLD prevalence: a systematic Review and meta-analysis","volume":"20","author":"Le","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"24","key":"10.1016\/j.ebiom.2023.104684_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413424","article-title":"It is high time physicians thought of natural products for alleviating NAFLD. Is there sufficient evidence to use them?","volume":"22","author":"Tarantino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2023.104684_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154925","article-title":"Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease","volume":"126","author":"Negi","year":"2022","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104684_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104684_bib7","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1007\/s12325-022-02153-x","article-title":"Efficacy of GLP-1 RA approved for weight management in patients with or without diabetes: a narrative Review","volume":"39","author":"Jensterle","year":"2022","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104684_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/en.2012-1937","article-title":"GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-\/-) mice","volume":"154","author":"Panjwani","year":"2013","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104684_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.21006","article-title":"Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob\/ob mice","volume":"43","author":"Ding","year":"2006","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104684_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049152","article-title":"GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE\u22173-Leiden mice","volume":"7","author":"Parlevliet","year":"2012","journal-title":"PLoS One"},{"issue":"10019","key":"10.1016\/j.ebiom.2023.104684_bib11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104684_bib12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A\u00a0placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104684_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.tem.2020.02.006","article-title":"How may GIP enhance the therapeutic efficacy of GLP-1?","volume":"31","author":"Samms","year":"2020","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104684_bib14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cmet.2019.07.013","article-title":"Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake","volume":"30","author":"Adriaenssens","year":"2019","journal-title":"Cell Metab"},{"issue":"209","key":"10.1016\/j.ebiom.2023.104684_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans","volume":"5","author":"Finan","year":"2013","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104684_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cmet.2017.07.011","article-title":"The sustained effects of a dual GIP\/GLP-1 receptor agonist, NNC0090-2746, in patients with type 2 diabetes","volume":"26","author":"Frias","year":"2017","journal-title":"Cell Metab"},{"issue":"10160","key":"10.1016\/j.ebiom.2023.104684_bib17","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104684_bib18","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/dom.13979","volume":"22","author":"Frias","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104684_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ijms21041509","article-title":"GIP as a potential therapeutic target for atherosclerotic cardiovascular disease-A systematic Review","volume":"21","author":"Mori","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104684_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/dom.12252","article-title":"APOE\u22173 Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome","volume":"16","author":"van den Hoek","year":"2014","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104684_bib21","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.ATV.0000243925.65265.3c","article-title":"Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE\u22173-Leiden mice","volume":"26","author":"Westerterp","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104684_bib22","doi-asserted-by":"crossref","first-page":"G602","DOI":"10.1152\/ajpgi.00081.2018","article-title":"Phenotypical heterogeneity in responder and nonresponder male ApoE\u22173 Leiden.CETP mice","volume":"315","author":"Tarasco","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104684_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237096","article-title":"RandoMice, a novel, user-friendly randomization tool in animal research","volume":"15","author":"van Eenige","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104684_bib24","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14820","article-title":"A\u00a0simplified procedure to trace triglyceride-rich lipoprotein metabolism in\u00a0vivo","volume":"9","author":"Ying","year":"2021","journal-title":"Physiol Rep"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104684_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115922","article-title":"Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology","volume":"9","author":"Liang","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104684_bib26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A\u00a0rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"10.1016\/j.ebiom.2023.104684_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100070","article-title":"Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE\u22173-Leiden.CETP mice","volume":"62","author":"van Eenige","year":"2021","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.ebiom.2023.104684_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2023.03.016","article-title":"Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE\u2217 3-Leiden. CETP mice","volume":"372","author":"van Eenige","year":"2023","journal-title":"Atherosclerosis"},{"issue":"31","key":"10.1016\/j.ebiom.2023.104684_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103304118","article-title":"Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation","volume":"118","author":"Embgenbroich","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104684_bib30","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1194\/jlr.R049437","article-title":"Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades","volume":"55","author":"Hofmann","year":"2014","journal-title":"J\u00a0Lipid Res"},{"issue":"22","key":"10.1016\/j.ebiom.2023.104684_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92902","article-title":"CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis","volume":"2","author":"Itoh","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104684_bib32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104684_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143690","article-title":"Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis","volume":"131","author":"Furuta","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104684_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077166","article-title":"Smooth muscle \u03b1 actin (Acta 2) and myofibroblast function during hepatic wound healing","volume":"8","author":"Rockey","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104684_bib35","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104684_bib36","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmet.2021.01.015","article-title":"The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell Metab"},{"issue":"41","key":"10.1016\/j.ebiom.2023.104684_bib37","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1523\/JNEUROSCI.3262-11.2011","article-title":"Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake","volume":"31","author":"Dossat","year":"2011","journal-title":"J\u00a0Neurosci"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104684_bib38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2011.02.001","article-title":"Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation","volume":"13","author":"Hayes","year":"2011","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104684_bib39","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/ATVBAHA.114.304873","article-title":"Central nervous system regulation of intestinal lipoprotein metabolism by glucagon-like peptide-1 via a brain-gut Axis","volume":"35","author":"Farr","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104684_bib40","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00125-009-1611-5","article-title":"The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice","volume":"53","author":"Hsieh","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.ebiom.2023.104684_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101590","article-title":"GLP-1 attenuates intestinal fat absorption and chylomicron production via vagal afferent nerves originating in the portal vein","volume":"65","author":"Hoffman","year":"2022","journal-title":"Mol Metab"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104684_bib42","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/dom.14328","article-title":"Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes","volume":"23","author":"Taskinen","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ebiom.2023.104684_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2019.102045","article-title":"Bile salts in digestion and transport of lipids","volume":"274","author":"Macierzanka","year":"2019","journal-title":"Adv Colloid Interface Sci"},{"issue":"36","key":"10.1016\/j.ebiom.2023.104684_bib44","doi-asserted-by":"crossref","first-page":"33920","DOI":"10.1074\/jbc.M306370200","article-title":"Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice","volume":"278","author":"Dawson","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"24","key":"10.1016\/j.ebiom.2023.104684_bib45","article-title":"The beneficial effects of apical sodium-dependent bile acid transporter inactivation depend on dietary fat composition","volume":"64","author":"van de Peppel","year":"2020","journal-title":"Mol Nutr Food Res"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104684_bib46","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00125-015-3727-0","article-title":"Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice","volume":"58","author":"Kooijman","year":"2015","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104684_bib47","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2337\/db17-0480","article-title":"The gluco- and liporegulatory and vasodilatory effects of glucose-dependent insulinotropic polypeptide (GIP) are abolished by an antagonist of the human GIP receptor","volume":"66","author":"Asmar","year":"2017","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104684_bib48","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1074\/jbc.M609088200","article-title":"Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade","volume":"282","author":"Kim","year":"2007","journal-title":"J\u00a0Biol Chem"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104684_bib49","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1194\/jlr.M006841","article-title":"GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene","volume":"51","author":"Kim","year":"2010","journal-title":"J\u00a0Lipid Res"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104684_bib50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/bph.12490","article-title":"Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration","volume":"171","author":"Wang","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104684_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2015.08.038","article-title":"Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis","volume":"64","author":"Armstrong","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ebiom.2023.104684_bib52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.molmet.2018.05.014","article-title":"The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE(-\/-) mice by blocking monocyte\/macrophage activation","volume":"14","author":"Kahles","year":"2018","journal-title":"Mol Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104684_bib53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104684_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/endrev\/bnaa032","article-title":"Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation","volume":"42","author":"McLean","year":"2021","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104684_bib55","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db09-1694","article-title":"Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4","volume":"59","author":"Arakawa","year":"2010","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104684_bib56","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2337\/dc19-1892","article-title":"Effects of novel dual GIP and GLP-1 receptor agonist tirzepatide on biomarkers of nonalcoholic steatohepatitis in patients with type 2 diabetes","volume":"43","author":"Hartman","year":"2020","journal-title":"Diabetes Care"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423002499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423002499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:26:02Z","timestamp":1762457162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423002499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":56,"alternative-id":["S2352396423002499"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104684","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE\u22173-Leiden.CETP mice","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104684"}}